Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.

Eun Hye Cho Min-Seung Park Hee-Yeon Woo Hyosoon Park Min-Jung Kwon

Published in: Journal of gynecologic oncology (2024)

Regardless of the cytology results, the risk of CIN 3 or worse was higher in HPV-16/HPV-18 than in other HR-HPV. HPV-16/HPV-18 genotyping is recommended to screen women with a high risk of cervical cancer.

Keyphrases

cervical cancer screening
high grade
high throughput